Camila (Progesterone)

Quick links

Choose a section

Quick links to important sections

Advertisements

Camila (Progesterone)

Selected form

Advertisements
Advertisements

Overview of Camila (Progesterone)

Quick Facts

Property Description
Active ingredient Norethindrone
Form Oral tablet
Pharmacological class Progestin, Contraceptive
Common use Prevention of pregnancy
Origin Synthetic (Progestational Agent)

What is Camila: A Progestin-Only Oral Contraceptive

Camila is a prescription-only medication identified as a Progestin-Only Pill (POP), a specific type of oral hormonal contraceptive indicated solely for the prevention of pregnancy. This medicine is commonly referred to as the minipill and is consistently provided as an oral tablet designed for continuous daily intake. The defining characteristic of the Progestin-Only Pill class is the complete exclusion of estrogen, which makes it a clinical alternative for individuals with medical conditions that contraindicate estrogen use, such as those with certain vascular risks or those who require contraception during breastfeeding. This single-component formulation is suitable for postpartum use as it does not interfere with lactation.

Active Composition and Classification of Norethindrone

The active ingredient in Camila is Norethindrone, a synthetic progestational agent belonging to the estrane class of progestin steroid hormones. Norethindrone is not the natural hormone progesterone, but a chemically modified derivative synthesized in a laboratory to deliver potent, targeted progestogenic effects when taken orally. Camila is a generic formulation of this single-hormone synthetic product, sharing its composition and function with several other commercially available minipills.

How the Minipill Achieves Pregnancy Prevention

The Norethindrone component acts by initiating simultaneous physiological changes within the female reproductive tract that collectively interfere with the process of conception. The mechanism involves the thickening of cervical mucus, creating a dense physical barrier that restricts the movement and penetration of sperm. Concurrently, the progestin alters the tissue structure of the endometrial lining (the uterine lining), making the environment unsuitable for the attachment and implantation of a fertilized egg. The effectiveness of the drug is based on these combined, localized actions that maintain an anti-conception state.

Regulatory References

  1. DailyMed - Camila (Norethindrone) prescribing information
  2. MedlinePlus - Progestin-only Contraceptives (Oral)
Advertisements

What side effects are possible with Camila (Progesterone)?

Possible Side Effects and Safety Information

The safety profile of Norethindrone, a progestin-only contraceptive, is structured around officially documented adverse reactions and strict use constraints. The most frequently observed effects relate to the reproductive system, with irregular genital bleeding, including spotting and breakthrough bleeding, listed as common, particularly during the initial months of use. Other effects categorized as common include headache, nausea, breast tenderness, and weight gain.

Adverse reactions are classified across several System-Organ Classes, encompassing effects on the nervous system (e.g., mood changes, depression), dermatological system (e.g., acne, alopecia, melasma), and metabolic processes.

Serious Adverse Reactions and Restrictions

Regulatory documentation highlights the risk of several serious adverse reactions, which, while often rare, must be noted. These include the risk of ectopic pregnancy, hepatic neoplasia (liver tumors), and thromboembolic events (blood clots), especially in individuals with high-risk behaviors like smoking. The official label establishes firm contraindications that restrict use in individuals with known or suspected carcinoma of the breast, acute liver disease, or undiagnosed abnormal genital bleeding. Safety notes also advise that certain pre-existing conditions, such as a history of depression or migraine headaches, warrant particular safety consideration.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Camila (Norethindrone) overdosage establishes that there have been no reports of serious ill effects documented in the prescribing information, including cases involving ingestion by children. The overdose is generally considered to be of low acute toxicity and is not expected to be life-threatening.

Documented manifestations of overdosage are limited to common, expected hormonal effects. These can include complaints such as nausea, vomiting, breast tenderness, and headache. Overdosage can also lead to alterations in the reproductive system, notably causing heavy vaginal bleeding or spotting, a manifestation that may be delayed by a few days post-ingestion.

Despite the documented low toxicity, immediate emergency medical attention is required if the affected individual exhibits any severe, non-specific health changes. You must contact the Poison Control Helpline or call emergency services immediately if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Management in a medical setting is strictly symptomatic and supportive, as the official labeling confirms that no specific antidote is known for this product. Hospital monitoring, including checks of vital signs and laboratory tests, may be performed as part of the supportive treatment protocol.

Advertisements

Therapeutic Uses of Camila (Progesterone)

Main Uses and Benefits of Camila (Progesterone)

The medicine is commonly used to help manage various symptoms related to systemic imbalance, often in a supportive regimen during hormonal transitions. It may be used for managing conditions involving episodic or fluctuating manifestations, which may present with systemic or localized discomfort. This application is considered relevant for easing distress when symptoms intensify and short-term symptomatic assistance is needed.

The approach assists with managing symptoms that interfere with daily comfort or create noticeable functional strain. It is used to provide supportive relief during difficult episodes, which assists with maintaining a sense of stability when symptoms become more noticeable. The medicine supports symptomatic relief in situations related to systemic imbalance. It is applied across domains where additional symptomatic support is needed for symptom clusters that may become intense or disruptive.


Quick Fact: Relief for Fluctuating Symptoms


Regulatory References

  1. NIH MedlinePlus overview of Progesterone
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Camila (Norethindrone)

Camila is an oral contraceptive intended for use by women of reproductive age seeking pregnancy prevention. Official regulatory documents define clear eligibility boundaries based on a patient's medical history, age, and reproductive status.

Populations for whom use is Contraindicated

The medicine must not be used by women who currently have the following conditions, as stated in the prescribing information:

  • Known or suspected pregnancy.
  • Known or suspected carcinoma of the breast.
  • Benign or malignant liver tumors or acute liver disease.
  • Undiagnosed abnormal genital bleeding.
  • Hypersensitivity to any component of the product.

Age and Condition Restrictions

Category Regulatory Status
Pediatric Use Use is not indicated before menarche (the first menstrual period).
Geriatric Use Not intended for use in postmenopausal or elderly women.
Lactation Generally considered the hormonal contraceptive of choice during breastfeeding.
Conditional Use Women with diabetes mellitus or conditions like migraine headaches or epilepsy must be carefully monitored.

Eligibility-related restrictions confirm that a history of ectopic pregnancy is not an absolute contraindication, but the possibility requires special vigilance.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Camila (Norethindrone) focuses heavily on how co-administered substances can alter its systemic concentration, which may affect contraceptive efficacy. The majority of significant drug-drug interactions are classified as pharmacokinetic and involve the Cytochrome P450 3A4 (CYP3A4) enzyme pathway.

Drug–Drug Interactions Affecting Norethindrone Exposure

Interaction Type Examples of Interacting Substances Official Regulatory Outcome
CYP3A4 Inducers Phenytoin, Carbamazepine, Rifampicin, Griseofulvin, Efavirenz May decrease Norethindrone levels, risking contraceptive failure.
CYP3A4 Inhibitors Itraconazole, Voriconazole, Fluconazole, Ritonavir May increase Norethindrone levels.

Contraindicated and Pharmacodynamic Interactions

Certain combinations are subject to specific regulatory restrictions. Co-administration is contraindicated with medications such as Acitretin and specific regimens for Hepatitis C (e.g., Ombitasvir/Paritaprevir/Ritonavir with or without Dasabuvir), due to either loss of efficacy or potential for severe adverse events.

Pharmacodynamic interference is documented with Ulipristal Acetate (an emergency contraceptive); regulatory guidance requires a separation window, with Norethindrone to be initiated no sooner than five days after Ulipristal Acetate intake. Norethindrone may also increase the systemic concentration of the immunosuppressant Cyclosporine.

Other Documented Interactions

The herbal product St. John's Wort ( extitHypericum perforatum) is officially documented to induce Norethindrone metabolism, potentially reducing its effectiveness. Grapefruit juice may also affect its blood levels through CYP3A4 inhibition.

Advertisements

Mechanism of Action

Camila, which contains norethindrone (a synthetic progestin), exerts its primary physiological modulation through interaction as an agonist with the nuclear progesterone receptor (PR) in target tissues like the hypothalamus, pituitary gland, cervix, and endometrium.

Intracellularly, agonist binding to the PR induces a conformational change, allowing the receptor to dimerize and translocate to the nucleus. This complex binds to Progesterone Response Elements (PREs) in DNA, modulating the transcription of specific target genes. This gene modulation has several downstream consequences.

At the systemic level, norethindrone establishes a negative feedback loop on the Hypothalamic-Pituitary-Gonadal (HPG) axis. This action decreases the pulse frequency of Gonadotropin-Releasing Hormone (GnRH) secretion from the hypothalamus, which, in turn, reduces the release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the anterior pituitary. This suppression of gonadotropin release can, in some cycles, inhibit follicular development and the subsequent mid-cycle LH surge.

Locally, in the cervix, it promotes the production of a thick, viscous cervical mucus, mechanically hindering the passage of sperm. In the endometrium, it induces secretory changes and leads to endometrial atrophy (thinning), modifying the environment of the uterine lining.

Advertisements

Dosage and Administration Information

Official Administration Protocol for Camila

Camila is an oral hormonal contraceptive administered as a single, fixed-dose tablet containing 0.35 mg of Norethindrone. The administration route is strictly oral and requires adherence to a continuous, fixed-dose schedule.

Dosing and Frequency

The required dosing regimen is one tablet taken once daily, with no scheduled interruption or inactive pills between 28-day packs. This pattern establishes the essential long-term, continuous use protocol for the medicine. Tablets must be ingested at the same time every day to maintain the necessary hormonal concentration.

Critical Timing and Missed Doses

Critical timing is a fundamental instruction. If a dose is taken more than 3 hours late or if a tablet is missed entirely, the protocol requires immediate action: the last missed dose must be taken as soon as possible, and a backup non-hormonal contraceptive method must be utilized for the subsequent 48 hours to maintain protection.

Population-Specific Guidelines

Specific administration rules apply to certain groups. The standard 0.35 mg daily dose regimen applies to postpubertal adolescents. For individuals postpartum, the timing of initiation is dependent on breastfeeding status, with guidance recommending starting the regimen between 3 to 6 weeks following delivery. This highly structured daily intake and precise handling of missed doses define the use protocol.

Advertisements

Recent Clinical Evidence

The core research for Camila was evaluated in clinical studies examining its role as a progestin-only oral contraceptive (POP). This evidence base includes large-scale clinical trials and post-marketing observational data consistent with regulatory standards for this drug class. Studies explored outcomes related to contraceptive goals observed in the context of typical daily use. Research describes patterns related to adherence, reporting different pregnancy rates when the pill was taken exactly as directed ("perfect use") compared to "typical use," suggesting that consistent timing was associated with the outcomes observed.

Researchers studied specific physiological changes, including monitoring the viscosity of cervical mucus, reporting findings related to its thickening. Studies also examined ovulation status. Findings indicate that while the pill affects mucus, full ovulation suppression was not the only change observed in all users, as ovulation was seen in a significant portion of cycles during the study period. The primary outcome examined was the Pearl Index, a measure used to track accidental pregnancies. Research also explored outcomes related to the return of the fertility cycle after discontinuation, reporting that patterns related to the resumption of ovulation were observed relatively soon in the studied populations.

Studies monitored special populations, including women who are breastfeeding and those in the postpartum period, examining outcomes related to the continuation of breastfeeding and infant outcomes. Data suggests the formulation was observed in these groups.

Research assessing outcomes typically covers periods up to one year. Long-term effects and outcomes beyond one year are not fully established across all available data sets. Key limitations highlighted by research include the high sensitivity of the measured outcomes to user consistency. Comparative evidence against newer contraceptive technologies is lacking in high-quality randomized trials, and limited information is available for long-term physiological effects in users where full ovulation suppression was not observed.

Key Studies & References

  1. DailyMed - CAMILA (norethindrone) tablet prescribing information (FDA Monograph)
  2. Progestin-Only Oral Contraceptives: Mechanisms and Efficacy (ACOG Practice Bulletin Summary)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Camila (Progesterone) (FAQ)


Q: What are the most common initial side effects of Camila (Progesterone)?

Official information indicates that common side effects reported include irregular bleeding, headache, breast tenderness, nausea, dizziness, acne, and weight gain. Irregular bleeding or spotting is an effect commonly reported by users, especially during the initial phase of treatment.


Q: How long does it typically take for the body to adjust to Camila?

Changes in menstrual bleeding patterns, such as spotting or irregular bleeding, are frequently observed. Regulatory guidance notes that these changes are especially common during the first 3 to 6 months of use, and this time frame is often referenced as an initial adjustment period, though individual experiences may vary.


Q: Can Camila be used to treat conditions other than contraception?

Norethindrone, the active ingredient in Camila, is a progestin that is also used in separate formulations and doses to treat certain conditions. These conditions may include endometriosis, secondary amenorrhea (the absence of menstrual periods), and irregular menstrual bleeding caused by hormonal imbalances.


Q: Is an increase in breast tenderness or pain a reported side effect of Camila?

Yes, breast tenderness is listed as a common side effect of this medication in official safety documents. More specific symptoms like enlarged breasts and mastalgia (breast pain) have also been reported in product summaries.


Q: Why do I need to be careful with the timing of my pill every day with Camila?

Taking the pill at the same time every day is highly important because the medication’s contraceptive protection may be significantly reduced if a dose is taken more than 3 hours late. Consistent daily timing is essential to maintain the necessary hormonal concentration for effectiveness.


Q: How can certain antibiotics or herbal supplements affect Camila's effectiveness?

Certain substances can interfere with the pill's action by affecting how the body processes the medication. Specific antibiotics, such as Rifampicin, and the herbal product St. John's Wort are known to decrease Norethindrone levels, which could increase the risk of unintended pregnancy.


Q: Is it necessary to use a backup method of contraception when starting Camila?

If the pill is started on any day other than the first day of a menstrual period, the product label instructs that a backup non-hormonal method of contraception, like a condom, should be utilized for the first 48 hours to ensure protection.


Q: Does Camila make a user more sensitive to the sun (melasma/dark patches)?

Melasma, which appears as brown, blotchy spots on sun-exposed skin, is a reported side effect. Official information about melasma advises that individuals with a history of this condition limit their exposure to the sun or ultraviolet light.


Q: What is the average time window for taking Camila before its effectiveness is reduced?

The daily tablet should be taken consistently, as the product label indicates contraceptive protection may be compromised if a dose is taken more than 3 hours late. This highlights the importance of precise daily timing for maintaining effectiveness.


Q: Why does Camila cause unpredictable changes in my menstrual cycle?

The active ingredient in Camila works by altering the uterine lining and adjusting hormone levels through a negative feedback loop on the body's natural system. This modulation can lead to changes in menstrual bleeding, frequently resulting in irregular, frequent, or occasionally absent periods.


Q: Is there a known link between Camila and weight changes (gain or loss)?

The regulatory documents list weight gain as a common side effect, and weight changes (both gain or loss) have been reported in safety summaries. The exact mechanism for these changes is not always detailed in the official prescribing information.


Q: What are the concerns about mood swings, anxiety, or depression while using Camila?

Mood changes and depression are reported side effects of the medication. Official safety notes state that conditions like a history of depression warrant particular safety consideration while using this medication. Anxiety and emotional changes have also been noted as possible adverse reactions.


Q: Does Camila commonly affect my sex drive or libido?

Official drug summaries note that changes in sexual desire can occur while taking this medication. Both a decrease in libido and, less commonly, an increase in libido are reported as possible adverse reactions.


Q: Can Camila make pre-existing acne worse?

Acne is listed as a possible side effect in the official prescribing information. Though the label reports acne generally, hormonal medications may influence existing skin conditions.


Q: What happens to my period if I stop taking Camila after using it for a long time?

After discontinuing the pill, the body should begin to resume its natural hormonal cycle. Fertility often returns quickly, and the first bleeding experienced is generally a withdrawal bleed, after which natural menstrual cycles should resume.


Q: Can the progestin in Camila cause increased vaginal discharge?

Yes, official drug summaries report that leukorrhea, which is defined as an increased vaginal discharge, is a noted adverse reaction. Vaginitis, or inflammation of the vagina, has also been reported.


Q: Is it true that Camila may be less effective at preventing ovulation than combined pills?

The primary clinical mechanism for Camila involves thickening the cervical mucus and altering the uterine lining. Research suggests that while the pill affects mucus, full ovulation suppression is not observed in all users.


Q: Can alcohol consumption interfere with the effectiveness of Camila?

Information regarding a minor interaction between the active ingredient, Norethindrone, and alcohol (ethanol) is available. Official sources note the potential for minor changes in the medication's effectiveness.


Q: Is there a link between Camila use and changes in cholesterol levels or diabetes risk?

The medication may cause a slight decrease in tolerance for glucose (sugar) and affect lipid metabolism, including a potential decrease in certain cholesterol levels. Official safety information notes that individuals with diabetes or prediabetes require particular safety consideration and monitoring.


Q: Can Camila affect the body's natural production of progesterone?

Yes, the medication works by establishing a negative feedback loop on the body's hormonal system. This action alters the release of reproductive hormones and prevents ovulation, thereby influencing the body's natural hormonal cycle and the release of endogenous progesterone.


Q: Are there any foods or drinks that should be avoided while on Camila?

Grapefruit and grapefruit juice are known to potentially interfere with how the body processes the medication. Official information notes that consuming these may increase the blood levels of the pill, which could lead to increased adverse effects.


Q: Can the side effects of Camila change over time, even after several months?

Side effects, particularly changes in bleeding patterns, are most common during the first few months of use. These effects often lessen over time with continuous use, suggesting the body's reaction and side effect profile can change after the initial adjustment period.


Q: Does Camila offer any relief for heavy or painful periods?

The active ingredient in Camila is also used therapeutically in certain medical conditions. Specifically, Norethindrone is prescribed to address conditions such as endometriosis and abnormal periods that involve heavy or irregular bleeding.


Q: What kind of check-ups are recommended while using Camila for contraception?

Official medical consensus suggests regular check-ups, often on an annual or semi-annual basis, may be considered while using hormonal contraception. These check-ups may include a pelvic exam and breast exam, as advised by a healthcare professional.


Q: Is it normal to experience hair thinning or increased hair growth on Camila?

Both changes in hair growth are reported as possible side effects in official summaries. Both hair loss (alopecia) and increased hair growth (hirsutism) have been listed as possible adverse reactions.


Q: Why is it important to tell my dentist or surgeon that I take Camila?

Official safety notes state that all healthcare providers, including dentists and surgeons, should be made aware that this medication is being used. This is important because the pill may affect the results of certain lab tests or may affect the rare, serious risk of adverse events like blood clots during major procedures.


Q: What should I know about the risk of ovarian cysts while on Camila?

Official medical literature notes that the use of this pill may lead to the formation of ovarian cysts. These formations are often asymptomatic and may not cause issues, but patients are generally advised to discuss any new or persistent abdominal discomfort.


Q: Can Camila be used in teenagers or women nearing menopause?

The medication is approved for use in women of reproductive age, including postpubertal adolescents (after the first menstrual period). Official guidance specifies that it is not intended for use in women who have reached menopause (postmenopausal women).


Q: Can my vision be affected while I am on Camila?

The product label states that sudden changes in vision, such as blurred vision or difficulty reading, should be addressed by a healthcare professional. Retinal thrombosis (a blockage in the blood vessels of the eye) is noted as a rare but serious possible reaction.


Q: Does Camila provide any protection against STIs?

No, hormonal contraceptives like Camila are indicated only for pregnancy prevention. They do not protect against HIV infection or any other sexually transmitted diseases (STDs/STIs).


Q: How long after starting Camila should my bleeding pattern become more regular?

Irregular bleeding is commonly reported during the first three to six months of use. The timeframe for bleeding to become more regular is variable among users, and persistent or very heavy bleeding may warrant a consultation with a healthcare professional for an evaluation.

Advertisements

How should Camila (Progesterone) be stored and disposed of?

How to Store and Dispose of Camila (Norethindrone)

Camila (norethindrone) tablets must be stored according to specific regulatory requirements to maintain product stability and effectiveness.


Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20°C to 25°C (68°F to 77°F).
Protection Keep away from excess heat, moisture, and direct light.
Container Must be kept in the original container and remain tightly closed.
Safety Like all medications, keep out of the sight and reach of children.

Disposal Guidelines

Unused or expired Camila must be disposed of safely. The primary method is to utilize an official drug take-back program. If this is unavailable, the tablets should be mixed with an undesirable substance (such as dirt or used coffee grounds) and placed into a sealed container before being thrown into the household trash. The tablets must not be flushed down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Camila (Progesterone) found in:

A-Z Index: